Farshad H Shirazi

8PUBLICATIONS
9CO-AUTHORS
Nanoscale characterisationPowder and particle technologyInstrumental methods (excl. immunological and bioassay methods)Medical infection agents (incl. prions)Cheminformatics and quantitative structure-activity relationships
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|May 01, 2026
Evaluating Inflammatory Gene Expression Linked to Chronic Obstructive Pulmonary Disease in Workers of the Nanoparticle Industries: A Cross-Sectional Study.

|May 01, 2026
Occupational Exposure to UPVC Powder Containing Calcium Carbonate (CaCO3) Nanoparticles: A Cross-Sectional Biological Monitoring and Qualitative Risk Assessment.

|Feb 03, 2025
Saliva Lipids May Determine Alprazolam Toxicity: An FTIR Study.

Arezou Mahdavinejad, Shahin Shadnia, Kiana Farhadinejad

|Mar 04, 2024
Design and Evaluation of a Novel Anti-microbial Peptide from Cathelicidin-2: Selectively Active Against Acinetobacter baumannii.

Fariba Fathi, Maryam Ghobeh, Farshad H Shirazi

|Jan 30, 2023
Synthesis, Structural Characterization, and Cytotoxic Activity of New Benzo[d]imidazo[2,1-b]thiazole Derivatives Against MCF-7 Breast Cancer Cells.

Nahid Ahmadi, Soraya Shahhosseini, Farshad H Shirazi

|Jun 29, 2022
The Complexity of Response to the Proliferation Agonist and Antagonist Agents, in the Breast Cancer Cell Lines with Various Receptors.

Narges Aryanpour, Golrokh Farnam, Reyhaneh Behtaj

Pageof 2

Frequent Collaborators

2 joint publications

Soqrat Omari Shekaftik

2 joint publications

Azadeh Ashtarinezhad

2 joint publications

Golrokh Farnam

1 joint publications

AghaFatemeh Hosseini